Timing of COC Denudation and Embryo Quality

December 12, 2019 updated by: Elif Esra Uyar, Acıbadem Atunizade Hospital

Timing of COC Denudation and Embryo Quality: A Prospective Randomised Sibling-Oocyte Study

The relation between the timing of COC denudation and oocyte /embryo quality is controversial. The aim of this study is to examine whether timing of denudation of sibling oocytes has any effect on embryo quality.

Study Overview

Status

Unknown

Conditions

Detailed Description

Retrieved sibling cumulus-oocyte complexes (COCs) will be randomly divided into two groups, in the first group denudation will be in 30 minutes after oocyte retrieval, in second group denudation will take place after 2 hours of incubation.

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34785
        • Recruiting
        • Acibadem Altunizade Hospitai
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Those infertile patients eligible for the study design who are planned to be treated with microinjection and has given written informed consent

Description

Inclusion Criteria:

  • COH with GnRH antagonist cycle
  • 5 or more oocytes collected

Exclusion Criteria:

  • Fewer than 4 oocytes after retrieval
  • Previous history of total fertilization failure or oocyte maturation arrest
  • Male partner requiring surgical sperm retrieval (MESA or TESA).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
early denudation
Cumulus-oocyte complexes will be denudated in 30 min after oocyte retrieval
COCs will be denudated in 30 min after oocyte retrieval
late denudation
Denudation will be done 2 hr after oocyte retrieval
COCs will be denudated 2 hr after oocyte retrieval

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of good quality cleavage embryos
Time Frame: 3 days after microinjection
Quality of embryos will be assessed morphologically on day 3
3 days after microinjection
Embryo utilization rate
Time Frame: 1 week after microinjection
Embryo utilization rate is defined as the number of embryos utilized (transferred or cryopreserved) per number of 2PN zygotes.
1 week after microinjection

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fertilization rate
Time Frame: 16-18 hour after microinjection
Proportion of injected oocytes with 2PN the day after injection
16-18 hour after microinjection
Cleavage rate
Time Frame: 2 days after microinjection
Proportion of cleaved zygotes on day 2
2 days after microinjection
Blastulation rate
Time Frame: 1 week after microinjection
Blastocyst rate per oocyte
1 week after microinjection

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 25, 2019

Primary Completion (Anticipated)

June 15, 2020

Study Completion (Anticipated)

June 25, 2020

Study Registration Dates

First Submitted

January 10, 2019

First Submitted That Met QC Criteria

January 21, 2019

First Posted (Actual)

January 23, 2019

Study Record Updates

Last Update Posted (Actual)

December 13, 2019

Last Update Submitted That Met QC Criteria

December 12, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • COCdenudation

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility, Female

Clinical Trials on early denudation

Subscribe